Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CROSSMARK GLOBAL HOLDINGS, INC. | 11/04/2024 | 16,117 | $655,000 | 100.00% | 0.03% |
| ADVISORS PREFERRED, LLC | 10/15/2024 | 2,022 | $81,514 | 100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 303 | $12,154 | 50.00% | 0.00% |
| MISSOURI TRUST & INVESTMENT CO | 11/05/2024 | 35 | $1,400 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BVF INC/IL | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| COLONIAL TRUST ADVISORS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/16/2024 | 0 | $0 | -100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| PLANNING CAPITAL MANAGEMENT CORP | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
Calliditas Therapeutics AB (publ)institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ). The most heavily invested institutionals were:
Crossmark Global Holdings, Inc.: 16,117
Advisors Preferred, LLC: 2,022
RHUMBLINE ADVISERS: 303
Missouri Trust & Investment Co: 35
MORGAN STANLEY: 0
Qube Research & Technologies Ltd: 0
0.03% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors.
Institutional investors have bought a total of 18,495 shares in the last 24 months. This purchase volume represents approximately $739,800 in transactions.